Dendritic cell vaccines for cancer therapy
- 1 August 2001
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 27 (4) , 247-255
- https://doi.org/10.1053/ctrv.2001.0221
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Immunity 2000Immunology Today, 2000
- Immunomodulation of cancer: potential use of selectively replicating agentsJournal of Clinical Investigation, 2000
- Therapeutic Vaccination for CancerClinical Immunology, 2000
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Genomic Views of the Immune SystemAnnual Review of Immunology, 2000
- Consequences of Cell DeathThe Journal of Experimental Medicine, 2000
- Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cellsImmunology Today, 1996
- Cancer antigens: immune recognition of self and altered self.The Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.The Journal of Experimental Medicine, 1994
- Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro.Journal of Clinical Investigation, 1990